{"hands_on_practices": [{"introduction": "Chelation therapy is a powerful tool, but its safety hinges on a precise understanding of chemical principles. A classic and critical example is the difference between disodium EDTA and calcium disodium EDTA for treating heavy metal poisoning. This practice challenges you to quantify the acute danger of administering the wrong form of EDTA by calculating the resulting drop in essential physiological ions, grounding a vital clinical precaution in the fundamental laws of chemical equilibrium. [@problem_id:4921742]", "problem": "A $70$-$\\text{kg}$ adult with lead poisoning is mistakenly administered a single intravenous dose of disodium ethylenediaminetetraacetic acid (EDTA), rather than the intended calcium disodium EDTA. Assume instantaneous distribution into the extracellular fluid (ECF) compartment of volume $V_{\\text{ECF}} = 14\\,\\text{L}$. The administered dose contains $n_{L} = 10.0\\,\\text{mmol}$ of the EDTA ligand, which you may treat as initially present as $\\text{EDTA}^{4-}$. Baseline ionized calcium concentration in the ECF is $C_{a0} = 1.20\\,\\text{mmol}\\,\\text{L}^{-1}$. At physiological $\\text{pH}\\,7.4$, the conditional formation constant for the $1{:}1$ complex $\\text{CaEDTA}^{2-}$ is $K_{f} = 1.0 \\times 10^{10}\\,\\text{L}\\,\\text{mol}^{-1}$. The chelation equilibrium is\n$$\\text{Ca}^{2+} + \\text{EDTA}^{4-} \\rightleftharpoons \\text{CaEDTA}^{2-},$$\nand it obeys the law of mass action. Neglect protein binding and kinetics (assume rapid equilibrium), and neglect competition from other metals.\n\nFor comparison, calcium disodium EDTA introduces $\\text{CaEDTA}^{2-}$ directly; at $t = 0^{+}$ this yields effectively zero free $\\text{EDTA}^{4-}$ available to chelate $\\text{Ca}^{2+}$, so ionized calcium does not acutely decrease.\n\nStarting from the law of mass action and mass balance, compute the fractional decrease in ionized calcium concentration immediately after distribution when disodium EDTA is given, relative to the calcium disodium EDTA case. Define the risk $r$ as\n$$r = \\frac{C_{a0} - [\\text{Ca}^{2+}]_{\\text{after}}}{C_{a0}}.$$\nExpress $r$ as a decimal number (unitless) and round your answer to three significant figures.", "solution": "The problem requires us to calculate the fractional decrease in ionized calcium concentration, denoted by $r$, following the administration of disodium EDTA. This is a chemical equilibrium problem involving chelation.\n\nFirst, we establish the initial conditions in the extracellular fluid (ECF) immediately after the administration and distribution of the drug. The volume of the ECF is given as $V_{\\text{ECF}} = 14\\,\\text{L}$.\n\nThe baseline ionized calcium concentration is $C_{a0} = [\\text{Ca}^{2+}]_0 = 1.20\\,\\text{mmol}\\,\\text{L}^{-1}$.\n\nThe administered dose of the EDTA ligand is $n_{L} = 10.0\\,\\text{mmol}$. Assuming this distributes instantaneously and uniformly throughout the ECF, its initial concentration, denoted $C_{L0}$, is:\n$$C_{L0} = [\\text{EDTA}^{4-}]_0 = \\frac{n_{L}}{V_{\\text{ECF}}} = \\frac{10.0\\,\\text{mmol}}{14\\,\\text{L}} = \\frac{5}{7}\\,\\text{mmol}\\,\\text{L}^{-1}$$\n\nThe chelation reaction is given by:\n$$\\text{Ca}^{2+} + \\text{EDTA}^{4-} \\rightleftharpoons \\text{CaEDTA}^{2-}$$\nThe conditional formation constant at physiological pH is given as $K_{f} = 1.0 \\times 10^{10}\\,\\text{L}\\,\\text{mol}^{-1}$. Since all concentrations are given in $\\text{mmol}\\,\\text{L}^{-1}$, we must convert the units of $K_f$ to be consistent.\n$$K_f = 1.0 \\times 10^{10}\\,\\frac{\\text{L}}{\\text{mol}} \\times \\frac{1\\,\\text{mol}}{10^3\\,\\text{mmol}} = 1.0 \\times 10^7\\,\\text{L}\\,\\text{mmol}^{-1}$$\n\nLet $x$ be the equilibrium concentration of the complex $[\\text{CaEDTA}^{2-}]$ in $\\text{mmol}\\,\\text{L}^{-1}$. Based on the stoichiometry of the reaction, the change in concentrations of the reactants is also $x$.\nThe equilibrium concentrations are:\n$$[\\text{CaEDTA}^{2-}]_{\\text{eq}} = x$$\n$$[\\text{Ca}^{2+}]_{\\text{eq}} = C_{a0} - x = 1.20 - x$$\n$$[\\text{EDTA}^{4-}]_{\\text{eq}} = C_{L0} - x = \\frac{5}{7} - x$$\n\nThe law of mass action gives the equilibrium expression:\n$$K_f = \\frac{[\\text{CaEDTA}^{2-}]_{\\text{eq}}}{[\\text{Ca}^{2+}]_{\\text{eq}} [\\text{EDTA}^{4-}]_{\\text{eq}}}$$\n$$1.0 \\times 10^7 = \\frac{x}{(1.20 - x)(\\frac{5}{7} - x)}$$\nThe value of $K_f$ is very large, which indicates that the equilibrium lies far to the right, and the reaction proceeds nearly to completion. This means the reaction will continue until one of the reactants, the limiting reactant, is almost entirely consumed.\n\nTo find the limiting reactant, we compare the initial concentrations:\n$$C_{a0} = 1.20\\,\\text{mmol}\\,\\text{L}^{-1}$$\n$$C_{L0} = \\frac{5}{7} \\approx 0.714\\,\\text{mmol}\\,\\text{L}^{-1}$$\nSince $C_{L0}  C_{a0}$, the EDTA ligand, $\\text{EDTA}^{4-}$, is the limiting reactant.\n\nThis implies that at equilibrium, the concentration of reacted species, $x$, will be very close to the initial concentration of the limiting reactant, $C_{L0}$.\n$$x \\approx C_{L0} = \\frac{5}{7}\\,\\text{mmol}\\,\\text{L}^{-1}$$\nThis approximation is justified because any significant amount of remaining $[\\text{EDTA}^{4-}]$ would, due to the large $K_f$, drive the reaction further to the right.\n\nUsing this approximation, we can calculate the final (equilibrium) concentration of ionized calcium, denoted as $[\\text{Ca}^{2+}]_{\\text{after}}$:\n$$[\\text{Ca}^{2+}]_{\\text{after}} = [\\text{Ca}^{2+}]_{\\text{eq}} = C_{a0} - x \\approx C_{a0} - C_{L0}$$\n$$[\\text{Ca}^{2+}]_{\\text{after}} \\approx 1.20\\,\\text{mmol}\\,\\text{L}^{-1} - \\frac{5}{7}\\,\\text{mmol}\\,\\text{L}^{-1}$$\n$$[\\text{Ca}^{2+}]_{\\text{after}} \\approx \\frac{12}{10} - \\frac{5}{7} = \\frac{6}{5} - \\frac{5}{7} = \\frac{42 - 25}{35} = \\frac{17}{35}\\,\\text{mmol}\\,\\text{L}^{-1}$$\n\nThe problem asks for the risk factor $r$, defined as the fractional decrease in ionized calcium concentration. The baseline concentration, $C_{a0}$, corresponds to the case where calcium disodium EDTA is given, which does not acutely lower $[\\text{Ca}^{2+}]$.\n$$r = \\frac{C_{a0} - [\\text{Ca}^{2+}]_{\\text{after}}}{C_{a0}}$$\nSubstituting our expression for $[\\text{Ca}^{2+}]_{\\text{after}}$:\n$$r \\approx \\frac{C_{a0} - (C_{a0} - C_{L0})}{C_{a0}} = \\frac{C_{L0}}{C_{a0}}$$\nNow, we substitute the numerical values for $C_{L0}$ and $C_{a0}$:\n$$r \\approx \\frac{\\frac{10.0\\,\\text{mmol}}{14\\,\\text{L}}}{1.20\\,\\text{mmol}\\,\\text{L}^{-1}} = \\frac{10.0}{14 \\times 1.20} = \\frac{10.0}{16.8}$$\n$$r \\approx \\frac{100}{168} = \\frac{25}{42}$$\nTo obtain the final answer, we compute the decimal value of this fraction and round to three significant figures.\n$$r \\approx 0.595238...$$\nRounding to three significant figures, we get $r \\approx 0.595$. This corresponds to a nearly $60\\%$ decrease in ionized calcium, a level consistent with severe, life-threatening hypocalcemia.", "answer": "$$\\boxed{0.595}$$", "id": "4921742"}, {"introduction": "Many life-saving antidotes function by directly competing with a toxin at its target receptor. To be effective, the antidote must be given at a sufficient concentration to displace the toxin and reverse its effects. This exercise translates the abstract concept of competitive antagonism into a practical clinical calculation, guiding you to determine the loading dose of an opioid antagonist needed to achieve a specific level of receptor occupancy in the face of an overdose. [@problem_id:4921754]", "problem": "A patient with acute opioid toxicity is to be treated with an intravenous competitive antagonist antidote that binds to the same receptor as the opioid agonist. Assume rapid distribution such that effect-site free concentrations equilibrate immediately with plasma free concentrations, and ignore protein binding and active metabolites. The therapeutic goal is to achieve a fraction of receptors occupied by the antidote of $F_{\\text{goal}} = 0.90$ to ensure prompt reversal.\n\nUse the following scientifically grounded starting points:\n- Under the law of mass action for a single binding site, the fraction of receptors occupied by a ligand with free concentration $[L]$ and dissociation constant $K_{d}$ is $\\theta = \\frac{[L]}{[L] + K_{d}}$.\n- For two ligands $A$ (antidote) and $T$ (toxin/agonist) competing for the same receptor site with dissociation constants $K_{A}$ and $K_{T}$ and free concentrations $[A]$ and $[T]$, the fraction of receptors occupied by the antidote is derived from the binding polynomial as $\\theta_{A} = \\frac{[A]/K_{A}}{1 + [A]/K_{A} + [T]/K_{T}}$.\n- The loading dose is the amount of drug required to instantly achieve a target plasma concentration, and is determined by the product of the target concentration and the apparent Volume of Distribution (Vd), where Volume of Distribution is defined as the proportionality constant relating the amount of drug in the body to the plasma concentration.\n\nGiven data:\n- Antidote dissociation constant $K_{A} = 1.0 \\times 10^{-9} \\ \\text{mol/L}$.\n- Toxin (opioid agonist) dissociation constant $K_{T} = 5.0 \\times 10^{-9} \\ \\text{mol/L}$.\n- Effect-site free concentration of the toxin $[T] = 1.0 \\times 10^{-8} \\ \\text{mol/L}$.\n- Antidote molecular weight $M_{A} = 327 \\ \\text{g/mol}$ (free base).\n- Patient body weight $W = 70 \\ \\text{kg}$.\n- Volume of Distribution (Vd) for the antidote $V_{d} = 2.0 \\ \\text{L/kg}$.\n- Desired antidote receptor occupancy $F_{\\text{goal}} = 0.90$.\n\nTasks:\n1. Using receptor theory and the competitive binding framework, determine the target free plasma concentration $C_{\\text{target}}$ of the antidote needed to achieve $\\theta_{A} = F_{\\text{goal}}$ in the presence of the competing toxin. Express $C_{\\text{target}}$ in $\\text{mg/L}$.\n2. Compute the intravenous loading dose required to instantaneously achieve $C_{\\text{target}}$ using the provided Volume of Distribution and patient weight. Express the final dose in $\\text{mg}$.\n\nRound the final dose to four significant figures and express it in $\\text{mg}$.", "solution": "The problem has been validated and found to be scientifically grounded, well-posed, and internally consistent. It is based on the fundamental principles of receptor pharmacology, specifically the law of mass action applied to competitive ligand binding. All necessary data are provided, and the parameters are within a realistic range for pharmacological scenarios. Therefore, a solution can be derived.\n\nThe primary goal is to determine the intravenous loading dose of a competitive antagonist required to achieve a specific level of receptor occupancy. This involves two main tasks: first, calculating the target plasma concentration of the antidote, and second, using this concentration to calculate the loading dose.\n\n**Task 1: Determine the target free plasma concentration ($C_{\\text{target}}$) of the antidote.**\n\nThe fraction of receptors occupied by the antidote ($A$) in the presence of a competing toxin ($T$) is given by the equation:\n$$\n\\theta_{A} = \\frac{[A]/K_{A}}{1 + [A]/K_{A} + [T]/K_{T}}\n$$\nwhere $[A]$ and $[T]$ are the free concentrations of the antidote and toxin, respectively, and $K_{A}$ and $K_{T}$ are their respective dissociation constants.\n\nThe problem requires achieving a target receptor occupancy of $\\theta_{A} = F_{\\text{goal}} = 0.90$. We need to solve the equation for $[A]$, which represents the required molar concentration of the antidote. Let's denote this target molar concentration as $C_{\\text{target, molar}}$.\n\nSetting $\\theta_{A} = F_{\\text{goal}}$:\n$$\nF_{\\text{goal}} = \\frac{C_{\\text{target, molar}}/K_{A}}{1 + C_{\\text{target, molar}}/K_{A} + [T]/K_{T}}\n$$\nTo solve for $C_{\\text{target, molar}}$, we rearrange the equation:\n$$\nF_{\\text{goal}} \\left( 1 + \\frac{[T]}{K_{T}} + \\frac{C_{\\text{target, molar}}}{K_{A}} \\right) = \\frac{C_{\\text{target, molar}}}{K_{A}}\n$$\n$$\nF_{\\text{goal}} \\left( 1 + \\frac{[T]}{K_{T}} \\right) + F_{\\text{goal}} \\frac{C_{\\text{target, molar}}}{K_{A}} = \\frac{C_{\\text{target, molar}}}{K_{A}}\n$$\n$$\nF_{\\text{goal}} \\left( 1 + \\frac{[T]}{K_{T}} \\right) = \\frac{C_{\\text{target, molar}}}{K_{A}} - F_{\\text{goal}} \\frac{C_{\\text{target, molar}}}{K_{A}}\n$$\n$$\nF_{\\text{goal}} \\left( 1 + \\frac{[T]}{K_{T}} \\right) = \\frac{C_{\\text{target, molar}}}{K_{A}} (1 - F_{\\text{goal}})\n$$\nIsolating $C_{\\text{target, molar}}$ gives:\n$$\nC_{\\text{target, molar}} = K_{A} \\left( \\frac{F_{\\text{goal}}}{1 - F_{\\text{goal}}} \\right) \\left( 1 + \\frac{[T]}{K_{T}} \\right)\n$$\nNow, we substitute the given values:\n- $K_{A} = 1.0 \\times 10^{-9} \\ \\text{mol/L}$\n- $K_{T} = 5.0 \\times 10^{-9} \\ \\text{mol/L}$\n- $[T] = 1.0 \\times 10^{-8} \\ \\text{mol/L}$\n- $F_{\\text{goal}} = 0.90$\n\nFirst, calculate the dimensionless terms:\n$$\n\\frac{F_{\\text{goal}}}{1 - F_{\\text{goal}}} = \\frac{0.90}{1 - 0.90} = \\frac{0.90}{0.10} = 9\n$$\n$$\n\\frac{[T]}{K_{T}} = \\frac{1.0 \\times 10^{-8} \\ \\text{mol/L}}{5.0 \\times 10^{-9} \\ \\text{mol/L}} = 2\n$$\nNow, substitute these back into the expression for $C_{\\text{target, molar}}$:\n$$\nC_{\\text{target, molar}} = (1.0 \\times 10^{-9} \\ \\text{mol/L}) \\times (9) \\times (1 + 2)\n$$\n$$\nC_{\\text{target, molar}} = (1.0 \\times 10^{-9} \\ \\text{mol/L}) \\times 27 = 2.7 \\times 10^{-8} \\ \\text{mol/L}\n$$\nThe problem requests the target concentration in units of $\\text{mg/L}$. We must convert the molar concentration to a mass concentration using the antidote's molecular weight, $M_{A} = 327 \\ \\text{g/mol}$. Let this be $C_{\\text{target}}$.\n$$\nC_{\\text{target}} = C_{\\text{target, molar}} \\times M_{A}\n$$\nThe result will be in $\\text{g/L}$, so we must multiply by $1000 \\ \\text{mg/g}$ to get $\\text{mg/L}$.\n$$\nC_{\\text{target}} \\ (\\text{mg/L}) = (2.7 \\times 10^{-8} \\ \\text{mol/L}) \\times (327 \\ \\text{g/mol}) \\times (1000 \\ \\text{mg/g})\n$$\n$$\nC_{\\text{target}} = 2.7 \\times 327 \\times 10^{-5} \\ \\text{mg/L} = 882.9 \\times 10^{-5} \\ \\text{mg/L}\n$$\n$$\nC_{\\text{target}} = 0.008829 \\ \\text{mg/L}\n$$\n\n**Task 2: Compute the intravenous loading dose.**\n\nThe loading dose ($D$) is the amount of drug needed to achieve the target concentration ($C_{\\text{target}}$) throughout the apparent Volume of Distribution ($V_{d}$). First, we calculate the total Volume of Distribution for the patient.\nGiven:\n- Patient body weight $W = 70 \\ \\text{kg}$\n- Volume of Distribution per unit weight $V_{d} = 2.0 \\ \\text{L/kg}$\n\nThe total Volume of Distribution, $V_{d, \\text{total}}$, is:\n$$\nV_{d, \\text{total}} = V_{d} \\times W = (2.0 \\ \\text{L/kg}) \\times (70 \\ \\text{kg}) = 140 \\ \\text{L}\n$$\nThe loading dose ($D$) is the product of the target mass concentration and the total Volume of Distribution:\n$$\nD = C_{\\text{target}} \\times V_{d, \\text{total}}\n$$\n$$\nD = (0.008829 \\ \\text{mg/L}) \\times (140 \\ \\text{L})\n$$\n$$\nD = 1.23606 \\ \\text{mg}\n$$\nThe problem requires the final dose to be rounded to four significant figures.\n$$\nD \\approx 1.236 \\ \\text{mg}\n$$\nThis is the required intravenous loading dose.", "answer": "$$\n\\boxed{1.236}\n$$", "id": "4921754"}, {"introduction": "Calculating an antidote dose becomes more complex when the drug being antagonized is continuously administered and eliminated by the body, requiring a dynamic, pharmacokinetic approach. This means one must determine how much drug remains at any given time to calculate the appropriate neutralizing dose. In this practice, you will model the neutralization of the anticoagulant heparin with its antidote, protamine, after a combination of bolus and infusion dosing, integrating principles of half-life and elimination to ensure precise and safe reversal. [@problem_id:4921787]", "problem": "A patient received Unfractionated Heparin (UFH) as follows: a bolus of $5000$ international units (IU) at time $t=0$ minutes, followed by a constant-rate infusion of $1000$ IU per hour from $t=30$ minutes to $t=90$ minutes. At time $T=105$ minutes after the bolus, you wish to fully neutralize the circulating UFH using protamine sulfate, using the rule that $1$ milligram (mg) of protamine neutralizes $100$ IU of UFH. Assume a one-compartment pharmacokinetic model with first-order elimination, so the amount of UFH in the body, $A(t)$, obeys the mass balance $\\frac{dA}{dt} = R(t) - k A(t)$, where $R(t)$ is the UFH input rate and $k$ is the first-order elimination rate constant. The UFH elimination half-life is $t_{1/2} = 60$ minutes, related to $k$ by $t_{1/2} = \\frac{\\ln 2}{k}$. Derive, from these fundamentals, the total amount of UFH remaining in the body at $t=T$, and use this to compute the protamine dose. Express the final dose in milligrams (mg) and round your answer to three significant figures.", "solution": "The problem is to determine the required dose of protamine sulfate to neutralize Unfractionated Heparin (UFH) at a specific time $T$. This requires calculating the total amount of UFH, $A(T)$, in the body at that time. The problem is based on a one-compartment pharmacokinetic model with first-order elimination.\n\nFirst, we validate the problem statement.\n\n### Step 1: Extract Givens\n- Initial bolus dose at $t=0$: $A_0 = 5000$ IU\n- Constant-rate infusion: $R_{inf} = 1000$ IU/hour\n- Infusion start time: $t_{start} = 30$ minutes\n- Infusion end time: $t_{end} = 90$ minutes\n- Time of neutralization: $T = 105$ minutes\n- Protamine neutralization rule: $1$ mg of protamine neutralizes $100$ IU of UFH\n- Pharmacokinetic model: $\\frac{dA}{dt} = R(t) - k A(t)$\n- UFH elimination half-life: $t_{1/2} = 60$ minutes\n- Half-life and rate constant relation: $t_{1/2} = \\frac{\\ln 2}{k}$\n- Requested output: Protamine dose in mg, rounded to three significant figures.\n\n### Step 2: Validate Using Extracted Givens\nThe problem is scientifically grounded, employing a standard one-compartment model which is a cornerstone of pharmacokinetics. The values for heparin half-life and the protamine neutralization ratio are clinically realistic. The problem is well-posed, providing all necessary information (a differential equation, initial/boundary conditions, and all parameters) to find a unique solution. The language is objective and unambiguous. The problem setup is self-contained and consistent. No flaws are identified.\n\n### Step 3: Verdict and Action\nThe problem is valid. We proceed with the solution.\n\nThe solution involves the following steps:\n1.  Determine the first-order elimination rate constant, $k$.\n2.  Define the UFH input rate function, $R(t)$.\n3.  Solve the differential equation to find the total amount of UFH, $A(T)$, at time $T = 105$ minutes.\n4.  Calculate the protamine dose based on $A(T)$.\n\n**1. Determine the elimination rate constant $k$**\nThe relationship between half-life $t_{1/2}$ and the first-order rate constant $k$ is given as $t_{1/2} = \\frac{\\ln 2}{k}$.\nGiven $t_{1/2} = 60$ minutes, we can solve for $k$:\n$$k = \\frac{\\ln 2}{t_{1/2}} = \\frac{\\ln 2}{60 \\text{ min}}$$\n\n**2. Define the UFH input function $R(t)$**\nThe total UFH input consists of a bolus at $t=0$ and a constant-rate infusion. The bolus is treated as an initial condition, $A(0) = 5000$ IU. The infusion provides a rate of input, $R(t)$. The infusion rate is given as $1000$ IU/hour, which must be converted to IU/minute to be consistent with the units of $k$.\n$$R_{inf} = 1000 \\frac{\\text{IU}}{\\text{hour}} \\times \\frac{1 \\text{ hour}}{60 \\text{ minutes}} = \\frac{1000}{60} \\frac{\\text{IU}}{\\text{min}}$$\nThe rate function $R(t)$ is a piecewise function defined over the interval of interest:\n$$R(t) = \\begin{cases} \\frac{1000}{60} \\frac{\\text{IU}}{\\text{min}}  \\text{for } 30 \\le t \\le 90 \\\\ 0  \\text{otherwise} \\end{cases}$$\nwhere time $t$ is in minutes.\n\n**3. Solve for the amount of UFH, $A(T)$**\nThe governing differential equation is a first-order linear ordinary differential equation:\n$$\\frac{dA}{dt} + kA(t) = R(t)$$\nThe system is linear, so the principle of superposition applies. The total amount of UFH at time $T$, $A(T)$, is the sum of the amount remaining from the initial bolus and the amount remaining from the infusion.\n$$A(T) = A_{bolus}(T) + A_{infusion}(T)$$\n\n**Amount from the bolus, $A_{bolus}(T)$:**\nThe amount of drug remaining from an initial bolus dose $A_0$ at time $t$ is given by $A_0 \\exp(-kt)$. At $T = 105$ minutes, the amount remaining from the bolus given at $t=0$ is:\n$$A_{bolus}(105) = A_0 \\exp(-k \\times 105) = 5000 \\exp(-105k)$$\n\n**Amount from the infusion, $A_{infusion}(T)$:**\nThe infusion from $t_{start} = 30$ to $t_{end} = 90$ can be viewed as a series of infinitesimal bolus doses, $dR = R_{inf} dt'$, administered at each time $t'$ within this interval. The amount of UFH remaining at time $T$ from an infinitesimal dose $dR$ given at time $t'$ is $dA = (R_{inf} dt') \\exp(-k(T-t'))$.\nTo find the total amount remaining from the entire infusion period, we integrate this expression from $t_{start}$ to $t_{end}$:\n$$A_{infusion}(T) = \\int_{t_{start}}^{t_{end}} R_{inf} \\exp(-k(T-t')) dt'$$\nSubstituting $T=105$, $t_{start}=30$, $t_{end}=90$, and $R_{inf} = \\frac{1000}{60}$:\n$$A_{infusion}(105) = \\int_{30}^{90} \\frac{1000}{60} \\exp(-k(105-t')) dt'$$\nTo solve the integral, we can pull out the constant terms:\n$$A_{infusion}(105) = \\frac{1000}{60} \\left[ \\frac{1}{k} \\exp(-k(105-t')) \\right]_{t'=30}^{t'=90}$$\nEvaluating at the limits of integration:\n$$A_{infusion}(105) = \\frac{1000}{60k} \\left[ \\exp(-k(105-90)) - \\exp(-k(105-30)) \\right]$$\n$$A_{infusion}(105) = \\frac{1000}{60k} \\left[ \\exp(-15k) - \\exp(-75k) \\right]$$\nNow, substitute $k = \\frac{\\ln 2}{60}$:\n$$\\frac{1000}{60k} = \\frac{1000}{60 \\left(\\frac{\\ln 2}{60}\\right)} = \\frac{1000}{\\ln 2}$$\nSo the expression for the amount from the infusion becomes:\n$$A_{infusion}(105) = \\frac{1000}{\\ln 2} \\left[ \\exp(-15k) - \\exp(-75k) \\right]$$\n\n**Total amount, $A(105)$:**\nSumming the contributions from the bolus and the infusion:\n$$A(105) = 5000 \\exp(-105k) + \\frac{1000}{\\ln 2} \\left( \\exp(-15k) - \\exp(-75k) \\right)$$\nNow we substitute $k = \\frac{\\ln 2}{60}$ into the exponential terms. Using the property $\\exp(c \\ln x) = x^c$:\n- $\\exp(-105k) = \\exp\\left(-105 \\frac{\\ln 2}{60}\\right) = \\exp\\left(-\\frac{7}{4} \\ln 2\\right) = 2^{-7/4} = 2^{-1.75}$\n- $\\exp(-15k) = \\exp\\left(-15 \\frac{\\ln 2}{60}\\right) = \\exp\\left(-\\frac{1}{4} \\ln 2\\right) = 2^{-1/4} = 2^{-0.25}$\n- $\\exp(-75k) = \\exp\\left(-75 \\frac{\\ln 2}{60}\\right) = \\exp\\left(-\\frac{5}{4} \\ln 2\\right) = 2^{-5/4} = 2^{-1.25}$\n\nSubstituting these into the expression for $A(105)$:\n$$A(105) = 5000 \\cdot 2^{-1.75} + \\frac{1000}{\\ln 2} (2^{-0.25} - 2^{-1.25})$$\nNow, we calculate the numerical value:\n- $2^{-1.75} \\approx 0.2973018$\n- $2^{-0.25} \\approx 0.8408964$\n- $2^{-1.25} \\approx 0.4204482$\n- $\\ln 2 \\approx 0.6931472$\n\n$A(105) \\approx 5000(0.2973018) + \\frac{1000}{0.6931472} (0.8408964 - 0.4204482)$\n$A(105) \\approx 1486.509 + 1442.695 (0.4204482)$\n$A(105) \\approx 1486.509 + 606.565$\n$A(105) \\approx 2093.074$ IU\n\n**4. Calculate the protamine dose**\nThe rule is $1$ mg of protamine for every $100$ IU of circulating UFH.\n$$\\text{Dose (mg)} = \\frac{A(105) \\text{ [IU]}}{100 \\text{ [IU/mg]}}$$\n$$\\text{Dose} = \\frac{2093.074}{100} = 20.93074 \\text{ mg}$$\nThe problem asks for the result to be rounded to three significant figures.\n$$\\text{Dose} \\approx 20.9 \\text{ mg}$$", "answer": "$$\\boxed{20.9}$$", "id": "4921787"}]}